The introduction of highly effective direct-acting antivirals has transformed the HCV treatment landscape, enabling cure ...

Hepatitis C is the leading cause of chronic liver disease and liver cancer in the world and affects an estimated 51 million people globally. Though the viral infection is easily diagnosable and ...

For a decade now, the world has had highly effective medications for hepatitis C infections. In the United States, they’ve mostly been sitting on the shelf, according to a new study. These drugs, ...

Asymptomatic disease and early progression. The progression of HCV infection to cirrhosis is often asymptomatic and clinically silent. In chronic hepatitis, the correlation of biochemical liver ...

Hepatitis C is a serious viral infection that can scar your liver, cause your liver to fail and raise your risk for liver cancer, but there are a multitude of medications that can treat it. According ...

Hepatitis C virus (HCV) infects an estimated 50 million people worldwide, according to the World Health Organization, and remains a leading cause of cirrhosis and liver cancer. While antiviral drugs ...

Following the identification of hepatitis A virus (HAV) and hepatitis B virus (HBV), it was apparent that additional hepatotropic viruses existed. Initially, they were grouped as non-A, non-B ...

For decades, many Americans with hepatitis C have struggled to get tested or died waiting for a cure that remained inaccessibly expensive within the nation’s fractured health care system. President ...

In the wake of recent breakthroughs in the management of hepatitis C virus (HCV) infection, with several new promising medications available on the market and more being studied in clinical trials, it ...